Why Choose Australia
Leveraging Australia’s local clinical, regulatory, and commercial advantages enables sponsors to deliver trials with greater cost efficiency, speed, and data quality.
Overview
Cost-efficiency
Australia offers cost advantages for sponsors through its R&D Tax Incentive, which can significantly reduce the net cost of conducting clinical trials. To fully realise these benefits, trials must be appropriately structured and costed in line with current Australian R&D Tax Incentive guidance.
Speed
Australia’s clinical trial framework is recognised for its efficiency and flexibility, enabling studies to commence quickly without compromising quality. Streamlined regulatory pathways reduce duplication and administrative burden, allowing sponsors to initiate studies and generate data faster.
Australia offers a mature, high-quality clinical research ecosystem, supported by leading universities, specialist research institutes, experienced CROs, and established clinical trial networks. Data generated in Australia is globally recognised and routinely supports international regulatory submissions, underpinned by strong scientific standards and robust intellectual property protection.